University of Maryland, Baltimore
8 articles with University of Maryland, Baltimore
It should be no surprise that the Washington, DC and Baltimore areas are considered strong for life sciences. This is BioSpace’s BioCapital Community Hotbed.
Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.
Hoth Therapeutics, Inc. announced that Hoth Therapeutics, Inc. (Hoth) has entered into a Commercial Evaluation Sublicense and Option Agreement with the University of Maryland, Baltimore (UMB) and Isoprene Pharmaceuticals Inc.
National Institute for Innovation in Manufacturing Biopharmaceuticals Funds UMB Researcher
A team of researchers at IBBR is showing how engineered multi-specific antibodies appear to be highly effective at preventing infection across a broad range of HIV-1 virus strains.
University of Maryland, Baltimore Grants Pataigin, LLC, Rights To Technology Developed For Rapid, Point-Of-Care Identification Of Dangerous Pathogens
University of Maryland, Baltimore Grants Glycocept Rights To A Technology Designed To Increase The Efficacy Of Therapeutic Monoclonal Antibodies
Educational & Scientific, LLC And University of Maryland, Baltimore, Sign An Agreement To Develop And Commercialize Novel Treatment For Major Cancers
The University of Maryland, Baltimore and Paragon Bioservices Announce the Formation of a Public-Private Stem Cell Technology Consortium